Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
19studies shown
Showing 1-12 of 19
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.

In Australia
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.

In Australia
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Other study type icon
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study is completed. It focuses on bipolarity and currently lists study information in Australia, India, and the United States.

In Australia
Bipolarity, DepressionOtherOver 18 Years
Countries
United States, Australia, India
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This study is completed. It focuses on bipolarity and currently lists study information in Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, and the United States.

In Australia
BipolarityOtherOver 18 Years
Countries
United States, Australia, France, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
Device study icon
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity type I

This study is active but not recruiting. It focuses on bipolarity and currently lists study information in the United States, Australia, and Canada.

In Australia
Bipolarity, SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
Countries
United States, Australia, Canada
Sponsor
diaMentis Inc.
Condition
Bipolarity, Schizophrenia
Behavioral study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study has public registry information in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

In Australia
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Bipolarity | Clinical Trials | HopeStage Research